Search Within

Edmund King Bartlett

Formats
  1. Journal Article (34)
  2. Meeting Abstract (24)
  3. Review (6)
  4. Miscellaneous (5)
  5. Correspondence (4)
  6. Editorial (3)
  7. Guidelines (1)
Groups
  1. CTCR Scholars (77)
  2. MSK Grad Students (77)
  3. Master of Science in Clinical and Translational Cancer Research (77)
  4. Melanoma Disease Management Team (77)
  5. Surgery (77)
  6. Department of Medicine (41)

More Groups

People
  1. Charlotte Ariyan (25)
  2. Daniel Coit (23)
  3. Michael Marchetti (19)
  4. Danielle Bello (15)
  5. Mary Brady (14)
  6. Ciara Kelly (12)

More People

Years
  1. 2025 (5)
  2. 2024 (7)
  3. 2023 (20)
  4. 2022 (14)
  5. 2021 (9)
  6. 2020 (14)

More Years

Publications
  1. Annals of Surgical Oncology (27)
  2. Journal of the American College of Surgeons (8)
  3. JAMA Dermatology (5)
  4. Journal of Surgical Oncology (5)
  5. Journal of the American Academy of Dermatology (4)
  6. Annals of Oncology (3)

More Publications

Publishers
  1. Springer (27)
  2. Elsevier Science, Inc. (8)
  3. Wiley Blackwell (8)
  4. American Medical Association (7)
  5. American Society of Clinical Oncology (5)
  6. Oxford University Press (5)

More Publishers

Results (77)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade
    Journal Article

    Babatunde, O. O.; Membribes, S. C.; Anthonescu, C.; Bradic, M.; O'Malley, B.; Linkov, I.; Bartlett, E.; Momtaz, P.; Alektiar, K.; Gounder, M. M.; more...
    npj Precision Oncology (2025)

    Fulltext@MSK | Save
  • ASO Author Reflections: Eroding utility of prognostic tools for melanoma sentinel lymph node metastasis during two decades
    Miscellaneous

    Drebin, H. M.; Kurtansky, N. R.; Marchetti, M. A.; Bartlett, E. K.
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Declining clinical utility of tools for predicting sentinel lymph node biopsy status: A single institution experience from 2000 to 2021
    Journal Article

    Drebin, H. M.; Kurtansky, N. R.; Hosein, S.; Nadelmann, E.; Moy, A. P.; Ariyan, C. E.; Bello, D. M.; Brady, M. S.; Coit, D. G.; Marchetti, M. A.; more...
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Society of Surgical Oncology Consensus statement: Assessing the evidence for and utility of gene expression profiling of primary cutaneous melanoma
    Guidelines

    Bartlett, E. K.; O'Donoghue, C.; Boland, G.; Bowles, T.; Delman, K. A.; Hieken, T. J.; Moncrieff, M.; Wong, S.; White, R. L. Jr; Karakousis, G.; more...
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Contemporary trends in utilization of metastasectomy in the era of targeted and immunotherapies
    Journal Article

    Passman, J. E.; Kallan, M. J.; Roberson, J. L.; Ginzberg, S. P.; Amjad, W.; Soegaard Ballester, J. M.; Tortorello, G.; Fraker, D.; Karakousis, G. C.; Bartlett, E. K.; more...
    Cancer (2025)

    Fulltext@MSK | Save
  • Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Kelly, C. M.; Bradic, M.; Saunds, S.; Avutu, V.; Chan, J.; D'Angelo, S. P.; Dickson, M.; Gounder, M.; Keohan, M. L.; Movva, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • An open label phase IIa study evaluating the preliminary efficacy of intratumoural tigilanol tiglate (TT) in advanced and/or metastatic soft tissue sarcoma (STS)
    Meeting Abstract

    Bartlett, E. K.; Li, D.; Shemla, S.; Ariyan, C. E.; Dickinson, S.; Crago, A.; Li, G.; Agaram, N.; D'Angelo, S. P.; Maki, R. G.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Locoregional efficacy of isolated limb infusion (ILI) in advanced melanoma in the modern era
    Meeting Abstract

    Shemla, S.; Vancheswaran, A.; Bartlett, E. K.; Bello, D. M.; Ariyan, C. E.
    Journal of the American College of Surgeons (2024)

    Fulltext@MSK | Save
  • Long-term outcomes of advanced melanoma patients resected to no evidence of disease following immune checkpoint blockade
    Meeting Abstract

    Sreeram, A.; Bartlett, E. K.; Ariyan, C. E.; Bello, D. M.
    Journal of the American College of Surgeons (2024)

    Fulltext@MSK | Save
  • Telomerase reverse transcriptase (TERT) promoter mutations are associated with higher tumor mutational burden and UV mutational signature in melanoma
    Meeting Abstract

    Leinwand, J. C.; Koh, E.; Bartlett, E.; Bello, D.; Brady, M. S.; Harding, J. J.; Morris, L.; Ariyan, C.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save